灿华
Lv7
3770 积分
2021-12-08 加入
-
Efficacy and Safety of Roxadustat for Anemia in Patients Receiving Chemotherapy for Nonmyeloid Malignancies: A Randomized, Open-Label, Active-Controlled Phase III Study
22天前
已完结
-
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis
30天前
已完结
-
Roxadustat for Anemia in Patients with Chronic Kidney Disease
30天前
已完结
-
On the Increased Event Rate of Urinary Tract Infection and Pneumonia in CKD Patients Treated with Roxadustat for Anemia
1个月前
已关闭
-
A phase 3b, multicenter, open‐label, single‐arm study of roxadustat (ASPEN): Operational learnings within United States dialysis organizations
1个月前
已完结
-
Infection and infestation-related adverse events of biologics in psoriasis: insights from the food and drug administration adverse event reporting system (FAERS)
1个月前
已完结
-
Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan
1个月前
已完结
-
Post-marketing safety of finerenone: a disproportionality analysis of the FDA adverse event reporting system
3个月前
已完结
-
Development, Quality by Design-Based Optimization, and Stability Assessment of Oral Liquid Formulations Containing Baclofen for Hospital Use
7个月前
已完结
-
Global, regional, and national burdens of HIV and other sexually transmitted infections in adolescents and young adults aged 10–24 years from 1990 to 2019: a trend analysis based on the Global Burden of Disease Study 2019
8个月前
已完结